{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:01:52Z","timestamp":1757700112178},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.7759\/cureus.29868","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T15:32:53Z","timestamp":1664811173000},"source":"Crossref","is-referenced-by-count":1,"title":["Targeted Screening for Gaucher Disease in High Suspicion Patients and Clinical Profile of Screen Positives in a Large Pediatric Multispecialty Hospital"],"prefix":"10.7759","author":[{"given":"Suvarna","family":"Magar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Engade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Idhate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Khambayate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaikh","family":"Nilofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000411","article-title":"Gaucher's disease: a review","volume":"30","author":"Morales LE","year":"1996","unstructured":"Morales LE. Gaucher's disease: a review. Ann Pharmacother. 1996, 30:381-8. 10.1177\/106002809603000411","journal-title":"Ann Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk L","year":"2017","unstructured":"Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017, 22:65-73. 10.1080\/10245332.2016.1240391","journal-title":"Hematology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21305","article-title":"Life expectancy in Gaucher disease type 1","volume":"83","author":"Weinreb NJ","year":"2008","unstructured":"Weinreb NJ, Deegan P, Kacena KA, Mistry P, Pastores GM, Velentgas P, vom Dahl S. Life expectancy in Gaucher disease type 1. Am J Hematol. 2008, 83:896-900. 10.1002\/ajh.21305","journal-title":"Am J Hematol"},{"key":"ref4","article-title":"The pathology of Gaucher disease","volume":"95","author":"Lee RE","year":"1982","unstructured":"Lee RE. The pathology of Gaucher disease. Prog Clin Biol Res. 1982, 95:177-217.","journal-title":"Prog Clin Biol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb NJ","year":"2002","unstructured":"Weinreb NJ, Charrow J, Andersson HC, et al.. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. 2002, 113:112-9. 10.1016\/s0002-9343(02)01150-6","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.01.050","article-title":"Gaucher disease: lessons from a decade of therapy","volume":"144","author":"Grabowski GA","year":"2004","unstructured":"Grabowski GA. Gaucher disease: lessons from a decade of therapy. J Pediatr. 2004, 144:S15-9. 10.1016\/j.jpeds.2004.01.050","journal-title":"J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.3549.3549","article-title":"A report from the International Collaborative Gaucher Group (ICGG) Gaucher Registry","volume":"112","author":"Weinreb NJ","year":"2008","unstructured":"Weinreb NJ, vom Dahl S. A report from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Blood. 2008, 112:3549. 10.1182\/blood.V112.11.3549.3549","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-014-1628-8","article-title":"The face of lysosomal storage disorders in India: a need for early diagnosis","volume":"82","author":"Agarwal S","year":"2015","unstructured":"Agarwal S, Lahiri K, Muranjan M, Solanki N. The face of lysosomal storage disorders in India: a need for early diagnosis. Indian J Pediatr. 2015, 82:525-9. 10.1007\/s12098-014-1628-8","journal-title":"Indian J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5064-20","article-title":"Screening for Gaucher disease using dried blood spot tests: a Japanese multicenter, cross-sectional survey","volume":"60","author":"Miyamoto T","year":"2021","unstructured":"Miyamoto T, Iino M, Komorizono Y, et al.. Screening for Gaucher disease using dried blood spot tests: a Japanese multicenter, cross-sectional survey. Intern Med. 2021, 60:699-707. 10.2169\/internalmedicine.5064-20","journal-title":"Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0782-x","article-title":"A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China","volume":"13","author":"Lei K","year":"2018","unstructured":"Lei K, Zhao Y, Sun L, et al.. A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China. Orphanet J Rare Dis. 2018, 13:48. 10.1186\/s13023-018-0782-x","journal-title":"Orphanet J Rare Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82296-z","article-title":"Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia","volume":"11","author":"Motta I","year":"2021","unstructured":"Motta I, Consonni D, Stroppiano M, et al.. Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia. Sci Rep. 2021, 11:2594. 10.1038\/s41598-021-82296-z","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2007.00811.x","article-title":"Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease","volume":"71","author":"Weinreb N","year":"2007","unstructured":"Weinreb N, Barranger J, Packman S, et al.. Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clin Genet. 2007, 71:576-88. 10.1111\/j.1399-0004.2007.00811.x","journal-title":"Clin Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12960","article-title":"Gaucher disease screening at a general adult hematology tertiary care centre: a prospective study","volume":"41","author":"Russell SA","year":"2019","unstructured":"Russell SA, Sholzberg M, Mangel J, et al.. Gaucher disease screening at a general adult hematology tertiary care centre: a prospective study. Int J Lab Hematol. 2019, 41:e66-9. 10.1111\/ijlh.12960","journal-title":"Int J Lab Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.03.016","article-title":"High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified","volume":"506","author":"Huang Y","year":"2020","unstructured":"Huang Y, Jia X, Tang C, et al.. High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified. Clin Chim Acta. 2020, 506:22-7. 10.1016\/j.cca.2020.03.016","journal-title":"Clin Chim Acta"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.06.005","article-title":"Validity of \u03b2-D-glucosidase activity measured in dried blood samples for detection of potential Gaucher disease patients","volume":"47","author":"Stroppiano M","year":"2014","unstructured":"Stroppiano M, Calevo MG, Corsolini F, et al.. Validity of \u03b2-D-glucosidase activity measured in dried blood samples for detection of potential Gaucher disease patients. Clin Biochem. 2014, 47:1293-6. 10.1016\/j.clinbiochem.2014.06.005","journal-title":"Clin Biochem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-016-0910-4","article-title":"Outcome of Gaucher disease in India: lessons from prevalent diagnostic and therapeutic practices","volume":"53","author":"Muranjan M","year":"2016","unstructured":"Muranjan M, Patil S. Outcome of Gaucher disease in India: lessons from prevalent diagnostic and therapeutic practices. Indian Pediatr. 2016, 53:685-8. 10.1007\/s13312-016-0910-4","journal-title":"Indian Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0759-1","article-title":"Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation","volume":"20","author":"Sheth J","year":"2019","unstructured":"Sheth J, Bhavsar R, Mistri M, et al.. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet. 2019, 20:31. 10.1186\/s12881-019-0759-1","journal-title":"BMC Med Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/117051-targeted-screening-for-gaucher-disease-in-high-suspicion-patients-and-clinical-profile-of-screen-positives-in-a-large-pediatric-multispecialty-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:12Z","timestamp":1707507612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/117051-targeted-screening-for-gaucher-disease-in-high-suspicion-patients-and-clinical-profile-of-screen-positives-in-a-large-pediatric-multispecialty-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.29868","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,3]]}}}